Clinical trial
Clinical and Molecular Studies of the Tumour Suppressor Gene PTEN in Endometrioid Type Endometrial Cancer
NCT02724501 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Molecular Studies of the Tumour Suppressor Gene PTEN in Endometrioid Type Endometrial Cancer
- Lead sponsor
- University Health Network, Toronto
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2000
- Completion date
- October 31, 2011
- Enrollment
- 217 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.